Objective. To evaluate the effectiveness of peripheral angioplasty (PTA) as the first-choice revascularisation procedure in diabetic patients with critical limb ischemia (CLI). Design. Prospective study. Methods. PTA was employed as first choice revascularisation in a consecutive series of diabetic patients hospitalized for CLI between January 1999 and December 2003. Results. PTA was successful performed in 993 patients. Seventeen (1.7%) major amputations were carried out. One death and 33 non-fatal complications were observed. Mean follow-up was 26G15 months. Clinical restenosis was observed in 87 patients. The 5 years primary patency was 88%, 95% CI 86-91%. During follow-up 119 (12.0%) patients died at a rate of 6.7% per year. Conclusions. PTA as the first choice revascularisation procedure is feasible, safe and effective for limb salvage in a high percentage of diabetic patients. Clinical restenosis was an infrequent event and PTA could successfully be repeated in most cases.
Successful revascularisation reduces the major amputation rate in diabetic patients presenting with critical limb ischemia (CLI). 1 The effectiveness of peripheral bypass grafts (BP) 2 and percutaneous transluminal angioplasty (PTA) 3 in achieving limb salvage has been established. 4, 5 Nonetheless in recent publications scepticism is still expressed concerning the feasibility, effectiveness and long-term results of PTA, particularly in the treatment of infrapopliteal disease. 6, 7 This is probably due to the absence of large-scale trials in the literature. 8 In comparison to BP few reports have evaluated the long-term results of PTA. 9, 10 In our protocol for the treatment of diabetic patients with TransAtlantic Inter-Society Consensus (TASC) criteria of CLI, 11 PTA is the first choice revascularisation procedure. PTA has a number of advantages: it does not require general or spinal anaesthesia, mortality is very low, complications are infrequent and a failed PTA attempt does not preclude a subsequent by-pass graft. 12 The aim of this study was to evaluate the effectiveness and the limits of PTA as the first-choice revascularisation procedure in a consecutive population of diabetic patients with CLI, with or without foot ulcer, hospitalised from January 1999 through December 2003 and followed until June 2004.
Materials and Methods

Protocol
All diabetic subjects referred to our two foot centres with foot ulcer or rest pain, were evaluated for the presence of pedal pulses and transcutaneous oxygen tension (TcPO 2 ) values. The posterior tibial and dorsalis pedis pulses were evaluated by palpation and a Doppler continuous wave technique. TcPO 2 was evaluated on the dorsum of the foot. In cases with reduced or absent foot pulses and TcPO 2 !50 mmHg, duplex scanning was performed. If haemodinamically significant stenoses were demonstrated during duplex scanning, arteriography was carried out and a PTA performed concomitantly, when possible. Fig. 1 shows the protocol flow-chart.
PTA procedure
PTA was indicated for angiographically documented stenoses O50% of the vessel diameter. 13 Stenoses and occlusions greater than 10 cm in length, consecutive multiple stenoses and also calcified occlusions were treated by PTA. Vessel recanalization was considered successful when direct flow was obtained in the treated vessel, with no significant residual stenosis along the whole artery. Fig. 2 shows an example of multiple stenoses successfully treated. In the absence of complications hospital stay for a PTA was 3 days. The procedure was performed under local anaesthesia through an antegrade puncture of the ipsilateral common femoral artery. If obstructions were present at duplex scanning in the iliac or common femoral artery, the puncture was performed by means of a contralateral approach. Rarely an open approach was performed, when the puncture in the inguinal area was difficult because of previous complicated surgery.
A five or six French gauge sheath was positioned to perform a preliminary angiographic study using diluted (50%) non-ionic contrast medium.
14 A 0.014-0.035 in. guide wire and a 3.0-5.0 French balloon catheter were used for the dilatation of 2-8 mm diameter arteries. We tried to avoid the use of stents especially in the infra popliteal arteries since the risk of thrombosis is very high in such low-flow vessels. Stents were employed if dissection or suboptimal results occurred. During the procedure, 5000-7000 IU of sodium heparin were infused into the arterial lumen. If vessel spasm occurred, 0.1-0.2 mg of nitroglycerine was infused as an intra-arterial bolus. Intra-arterial thrombus was managed by catheter aspiration and/or urokinase and heparin infusion. 15 A nephroprotection protocol was used in all nondialyzed patients: 1500 ml saline was infused the day before and the day after the procedure. In subjects with creatinine O110 mg/dl, dopamine 2g/Kg/min was infused 24 h before and after the procedure. In patients with an ejection fraction !40%, 20 mg of furosemide were injected intravenously at the beginning and the end of the daily hydration. Creatinine value was determined the day before and after the PTA. All the patients were prescribed either ticlopidine 500 mg/day or clopidogrel 75 mg/day for 30 days and subsequently acetyl salicylic acid 100 mg/day or ticlopidine 250 mg/day indefinitely.
Complications
Any event that required specific medical or surgical treatment or prolonged hospital stay following PTA was recorded and considered a complication. Haematoma formation at the puncture site was considered as a not significant side effect unless necessitating either surgery and/or packed red blood cell transfusion. 
Limb salvage
After PTA symptomatic outcome was evaluated and TcPO 2 values were reassessed 3-6 days after the procedure. 16 In patients presenting with rest pain without foot ulcer, the disappearance of pain was considered limb salvage successful. In patients with foot ulcers we considered limb salvage successful when the rest pain, if formerly present, disappeared and the plantar stand was maintained, even when achieved by a tarsal-metatarsal amputation. 17 Any above-the-ankle amputation, including the Syme amputation, was considered a failure.
Follow-up
After hospital discharge all the patients with foot ulcer were examined at our centres until complete ulcer healing occurred. All healed patients were provided with extra-deep rocker shoes with soft leather and customized insoles. Many patients were referred to our centres from other hospitals and once healed, they were discharged to their diabetes centres with the strict instructions to perform an immediate evaluation in case of ulcer or pain recurrence. Restenosis was assessed clinically based on pain or ulcer reappearance. In these situations TcPO 2 was reassessed and duplex scanning was performed. 18 If TcPO 2 was significantly worse (!15% of the post-PTA value) and duplex scanning was positive, the patient underwent a repeat angiographic evaluation and a further PTA, if possible. Asymptomatic restenosis (significant stenoses at duplex scanning without pain or ulcer worsening or recurrence) was not investigated. Clinical restenosis, new vascular procedures, new amputations and date of death were recorded. All the data regarding patients who were not followed directly by our centres were obtained from the colleagues treating these patients.
Statistical methods
Descriptive statistics are reported as average values and standard deviation for continuous variables and as percentages and contingency tables for the qualitative and discrete variables. The 66 months primary 
Results
Study population
Between June 1st 1999 and December 31st 2003, 1909 consecutive diabetic patients were hospitalised for foot ulcer or ischemic rest pain in our two diabetic foot centres. In 1191 patients at least one pedal pulse was reduced or absent, the transcutaneous oxygen tension was !50 mmHg and duplex scanning demonstrated stenoses O50% of vessel diameter. All these patients were referred for an angiographic study and, whenever possible, a concomitant PTA procedure. At angiography, three patients had no angiographic evidence of stenoses O50% of the vessel diameter.
These three patients were excluded from the analysis, leaving 1188 with CLI.
PTA as first-choice revascularisation procedure PTA was performed in 993 patients (83.6%) and in the remaining 195 (16.4%) was not feasible due the complete calcified occlusion of the vessel which did not permit balloon catheter passage. Table 1 report the demographic and clinical characteristics of the PTA treated patients. Obstructions of O50% of vessel diameter were located in the iliac/femoral/popliteal axis in 67 patients (6.7%), exclusively in the infrapopliteal axis in 316 patients (31.8%) and in both femoral-popliteal and infrapopliteal axis in 610 patients (61.4%). Table 2 reports the number and length of stenoses and occlusions. Of 993 patients treated with PTA, 983 obtained at least one open artery down to the foot: Fig. 3 shows the number of patients with obstructions in the infrapopliteal arteries before and after PTA.
Four hundred and five patients had a creatinine value %110 mg/dl: creatinine value before the procedure was 1.08G0.20 mg/dl, and after the procedure 1.07G0.33 mg/dl (pZ0.707). Five hundred and forty Fig. 4 .
PTA complications
Thirty-four (3.4%) complications occurred. One subject died suddenly the night following PTA. One patient underwent an above the knee amputation due to acute distal thrombosis not suitable for surgical revascularisation. Thirty-two complications required a specific therapy or a prolonged hospital stay. Table 3 reports the complications in the PTA group. 
Limb salvage
Follow-up
Nine hundred and seventy-one (97.8%) patients were followed-up in the period from January 1st 1999 to June 30 2004. Follow-up information was not available for 22 (2.2%) patients. The mean follow-up was 26.2G15.1 months, range 6.6-66 months, median 22.9 months. We observed 112 (11.3%) episodes of clinical restenosis in 87 (8.8%) patients. One episode occurred in 72 patients, two episodes in nine patients, three episodes in three patients, four episodes in two patients, five episodes in one patient. The KaplanMeier estimate of first episode of clinical restenosis was 2.2% per year. The primary patency at 5 years was 88%, 95% confidence interval 86-91%. Fig. 5 shows the Fig. 3 . Number of patients with obstructions in the infrapopliteal arteries before and after PTA (NZ993). Fig. 4 . TcPO 2 values distribution by 10 mmHg classes before (NZ993) and after (NZ937) PTA in study population.
Kaplan-Meier curve of first episode of clinical restenosis. Of the 87 patients in which clinical restenosis occurred, PTA procedures were successful repeated in 70 (80.5%) patients. In the remaining 17 patients (19.5%) a further PTA was not feasible. Out of the 971 followed patients, 119 (12.0%) died. The KaplanMeier estimate of death was 6.7% per year, 5 year survival 74%, confidence interval 66-80%. Fig. 6 shows the Kaplan-Meier survival curve. During the followup six patients who had a PTA at our centres and a healed ulcer underwent subsequent procedures in another institution: one PTA, one BP, two above and two below the knee amputations.
Discussion
The aim of the revascularisation procedure is 'to provide sufficient blood flow to relieve rest pain and heal skin lesions'. The ideal revascularisation procedure is the one that 'avoids a general anaesthesia, poses a lesser systemic stress, and has fewer serious complications'. We totally agree with these TransAtlantic Inter-Society Consensus (TASC) affirmations.
11
In diabetic patients occlusive peripheral disease is characterised by distal, multiple obstructions with a higher percentage of occlusions with respect to stenoses. 19 These data are confirmed in our study population. The most common morphological characteristics of the occlusive disease in our population corresponds to the type C and D of the TASC recommendation 93. In a previous publication 20 we demonstrated that PTA was feasible for the treatment of long, multiple and calcified stenoses and occlusions. The main obstacle to recanalization is the complete calcified occlusion of the vessel, which does not permit balloon catheter passage. This obstacle is absolutely independent of both the length and the number of obstructions in the artery. This study confirms the above described results on a larger patient population. Our protocol employs a PTA revascularisation attempt irrespective of the length, the number and the localisation of obstructions. This protocol let us obtain a high number of technical successes and a high limb salvage rate. This is especially true considering that PTA was able to recanalize at least one vessel down to the foot in 477 of the 487 patients who did not even have a single patent leg artery down to the foot. These results were obtained employing a procedure with low morbidity and mortality rate, which does not need either general or spinal anaesthesia, does not cause skin lesions and necessitates only a short hospital stay. The feasibility is very high considering that this procedure is consecutively performed in our whole population and not in selected patients with 'a priori' high success probabilities. Based on these results, we find the TASC recommendation 35 for the revascularisation technique of choice to be restrictive and believe 
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it is useful to attempt an endoluminal revascularisation in whatever type of stenosis or occlusion. We prefer to perform an open surgical revascularisation when endoluminal revascularisation is not possible or insufficient. We observed a single death which occurred the night following PTA in a cardiopathic patient. 21 Sudden death is particularly frequent in cardiopathic diabetic patients. 22 We also observed one patient with massive distal thrombosis: in this patient thrombolysis was ineffective, surgical revascularisation was considered unsuitable and a major amputation was carried out. All the other complications were resolved without major amputation. These data confirm that the side effects of PTA are very low and mortality is minimal, 23, 24 especially considering a study population such as ours in which the mean age was 70 years, with more than 60% being cardiopathic and many having renal insufficiency and hypertension.
In our protocol the angiographic study and PTA were performed in the same session. This approach reduces both patient stress and the amount of contrast administered, which are particularly relevant in subjects with cardiac or renal insufficiency. 25 The combination of a high technical success rate, a low complications rate and a high limb salvage rate are possible if the PTA physician is particularly skilled and patient care is performed by means of a skilled combined medical and surgical team. 26 PTA is thought by some operators to be of limited efficacy because of its supposedly high restenosis rate. The clinical restenosis rate in our series was low, and moreover, the restenosis was successfully manageable by a second PTA in many patients. The morphological restenosis is probably higher. Nevertheless, when tissue healing has occurred and no pain is present we consider a delayed closure of the recanalized vessel as clinically irrelevant. 27 The diagnostic and therapeutic protocol applied at our centre has not changed during the study period. We do not record ankle-brachial pressure index (ABI) due to the high percentage of patients with arterial calcification. 28 In our previous paper 20 ABI determination was not possible in 32.5% of patients. In this study population, among the first 200 patients enrolled this percentage was 41.8% and, therefore, we decided to abandon the registration of this index in the database. In our usual patient care the index is employed when possible and when it is impossible, pulses are acoustically searched for using continuous wave Doppler.
In conclusion, PTA is the first choice for revascularisation in diabetic ischemic foot. PTA is feasible in most patients, complications are infrequent and mortality is very low. Clinical restenosis was an infrequent finding and the procedure could successfully be repeated in most cases.
